Raqia Therapeutics begins operations in the Harvard Pagliuca Life Labs. Raqia is a new company based on technology developed in the Novina lab. Clinical advisors include Ken Anderson and Nikhil Munshi, who will help translate the BAT-CAR technology for patients with multiple myeloma.
|
The Novina Lab began work on two sponsored research agreement with Takeda regarding the platform for detecting RNA-protein interactions.
|
Novina Lab NewsArchives
July 2021
Categories
|
RSS Feed